Oral Ixazomib in Untreated Follicular Lymphoma Permits COVID-19 Vaccine Response and Its Efficacy Is Associated with Clinical Factors and Gene Expression Signatures
口服伊沙佐米可增强未经治疗的滤泡性淋巴瘤患者对新冠疫苗的反应，且其疗效与临床因素和基因表达特征相关。
期刊:Cochrane Database of Systematic Reviews
影响因子:9.4
doi:10.1002/14651858.CD007356.pub2
Lopez-Olivo, Maria Angeles; Amezaga Urruela, Matxalen; McGahan, Lynda; Pollono, Eduardo N; Suarez-Almazor, Maria E; Graf, Solomon A; Lynch, Ryan C; Ujjani, Chaitra S; Gooley, Ted A; Coffey, David G; Cowan, Andrew J; Smith, Stephen D; Shadman, Mazyar; Warren, Edus H; Libby, Edward; Godwin, Colin D; Greninger, Alexander L; Fromm, Jonathan R; Gopal, Ajay K
